NeuroMap System

Biomarker Myopathic Disease

Objective: Non-invasively measure clinically relevant motor unit information from patients with myopathic diseases

Biomarkers of Musculoskeletal Function: Myopathic Disease
Control vs Myopathy
Control and Myopathic Subjects MUAP


With a Galileo sensor over the FDI muscle, the NeuroMap System detected significant reductions in motor unit action potential amplitudes in myopathic patients, consistent with the progressive loss of muscle fibers that characterizes such diseases.